We are live on
!
Find out more
GIM
Greylin Investment Management Portfolio holdings
AUM
$598M
1-Year Est. Return
18.59%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+18.59%
3 Year Est. Return
+52.1%
5 Year Est. Return
+133.23%
10 Year Est. Return
+214.42%
AUM
$395M
AUM Growth
-$24.8M
(-5.9%)
Cap. Flow
-$922K
Cap. Flow
% of AUM
-0.23%
Top 10 Holdings %
Top 10 Hldgs %
76.48%
Holding
64
New
2
Increased
18
Reduced
30
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CHK
Chesapeake Energy Corporation
CHK
|
+$8.25M |
| 2 |
ExxonMobil
XOM
|
+$3.32M |
| 3 |
Bank of America
BAC
|
+$1.14M |
| 4 |
Imperial Oil
IMO
|
+$929K |
| 5 |
BP
BP
|
+$882K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$2.68M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$2.49M |
| 3 |
CSX Corp
CSX
|
+$2.37M |
| 4 |
Wells Fargo
WFC
|
+$1.71M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$1.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 36.19% |
| 2 | Energy | 20.18% |
| 3 | Healthcare | 10.49% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Materials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Oramed Pharmaceuticals
ORMP
$221M
| $256K | 0.06% |
45,100
-4,900
| -10% | -$33.5K |
|
52
Automatic Data Processing
ADP
$112B
| $254K | 0.06% |
3,170
-1,015
| -24% | -$86.5K |
|
53
Altria Group
MO
$115B
| $247K | 0.06% |
+5,050
| New | +$256K |
|
54
McDonald's
MCD
$188B
| $245K | 0.06% |
2,575
| – | – |
|
55
Texas Instruments
TXN
$239B
| $236K | 0.06% |
4,584
-100
| -2% | -$5.52K |
|
56
WisdomTree International Equity Fund
DWM
$694M
| $220K | 0.06% |
4,319
| – | – |
|
57
Intel
INTC
$461B
| $219K | 0.06% |
7,200
-900
| -11% | -$29.1K |
|
58
Clorox
CLX
$12.6B
| – | – |
-2,190
| Closed | -$228K |
|
59
iShares MSCI EAFE ETF
EFA
$80B
| – | – |
-3,412
| Closed | -$208K |
|
60
GSK
GSK
$103B
| – | – |
-17,764
| Closed | -$949K |
|
61
Southern Company
SO
$103B
| – | – |
-4,350
| Closed | -$214K |
|
62
Zimmer Biomet
ZBH
$19.3B
| – | – |
-6,736
| Closed | -$742K |
|
|
RDS.A
63
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| – | – |
-3,640
| Closed | -$228K |
|
|
DOM
64
DELISTED
DOMINION RES BLACK WARRIOR TR
DOM
| – | – |
-39,775
| Closed | -$227K |
|
Similar funds
MCM
PRC
SCM
IFAM
PWS
AT
JWM
TWM
Greylin Investment Management's Q2 2015 Portfolio in Review
As of Q2 2015, Greylin Investment Management held 64 positions worth $395M, down 5.9% from $420M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Greylin Investment Management's Q2 2015 filing shows 2 new, 18 increased, 30 reduced and 7 closed positions. Its largest new stake was Imperial Oil: 22,570 shares worth $872K. The largest sale was Merck, an estimated $2.68M.
By sector, the portfolio is most concentrated in Financials at 36% of assets, down from 38% a quarter earlier, followed by Energy and Healthcare.
- Greylin Investment Management's largest Q2 2015 buy was Imperial Oil: 22,570 shares worth $872K.
- Greylin Investment Management added most to Chesapeake Energy Corporation in Q2 2015, an estimated $8.25M increase.
- Greylin Investment Management's biggest Q2 2015 reduction was Merck, cutting an estimated $2.68M.
- Greylin Investment Management fully exited GSK in Q2 2015, selling an estimated $949K.
- Greylin Investment Management's ten largest holdings make up 76% of its $395M portfolio in Q2 2015.
- Greylin Investment Management opened 2 new positions and closed 7 in Q2 2015.
- Greylin Investment Management's portfolio value fell 5.9% quarter-over-quarter to $395M.
Based on Greylin Investment Management's 13F filing for Q2 2015, filed 22 Jul 2015.